Royal Emerald Pharmaceuticals Partners with BioHarvest Sciences to Supply Disruptive Cannabis Solutions to Companies Conducting FDA-Approved Medical Research
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 16, 2022) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV), a leading biotech company focused on plant bio-cells growth for the nutraceutical and the medicinal cannabis markets, today announced the signing of a binding Letter of Intent (LOI) with Royal Emerald Pharmaceuticals (REP), one of only seven Drug Enforcement Administration (DEA) bulk manufacturing registration holders permitted to grow marijuana in the United...
2022-11-16 7:44 AM EST
BioHarvest Sciences Inc. Announces Closing of the Second Tranche of Private Placement of Convertible Notes and Expects the Offering to Be Oversubscribed and to Close an Additional Tranche of up to $3 Million by December 15, 2022
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 7, 2022. Due to the significant demand for this offering, the Company expects the offering to be oversubscribed and to close an...
2022-11-15 1:56 PM EST
BioHarvest Sciences CEO to Detail Multi-Pronged Cannabis Strategy in North America at Online Webinar, Nov 16 at 2pm ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - November 14, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that CEO Ilan Sobel will host an online investor presentation on Wednesday, November 16. Following the October 25th breakthrough achievement and other important recent developments at BHSC and in the Cannabis market, the Company invites all interested investors and media to register for this event, where Ilan...
2022-11-14 1:59 PM EST
BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 25, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") reveals today the detailed anal
2022-10-25 8:05 AM EDT
BioHarvest Sciences Inc. Announces Closing of the First Tranche of Private Placement of Convertible Notes
Rehovot, Israel--(Newsfile Corp. - October 13, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on April 7, 2022 and October 7, 2022. Under the First Tranche, the Company has issued Notes in the aggregate principal amount of $6,878,243.65 CAD. In connection with the...
2022-10-13 7:30 AM EDT
BioHarvest Sciences Inc. Announces the Oversubscription of Private Placement of Convertible Notes and Change in Note Terms.
Rehovot, Israel--(Newsfile Corp. - October 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that its non-brokered private placement of convertible notes (the "Notes") previously announced of up to $6,300,000 CAD has been oversubscribed and has now been increased to up to $10,000,000 CAD in order to further accelerate VINIA® sales growth and Cannabis commercialization activities in North America. The Company also...
2022-10-07 7:30 AM EDT
BioHarvest Sciences Inc. Reports Record Sales Results in Q3 2022 with Strong Momentum Building on All Fronts
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 3, 2022) - BioHarvest Sciences Inc. (CS
2022-10-03 7:30 AM EDT
Business Intelligence Group Awards BioHarvest Sciences with the Prestigious Sustainability Leadership Award
The award recognizes the sustainability impact of BioHarvest's Bio Plant CELLicitation technology, which enables industrial production of plant metabolites without growing the plant itself BioHarvest Sciences receives the award with other industry thought leaders such as AstraZeneca, Agilent, and Honeywell F
2022-09-06 7:30 AM EDT
BioHarvest Sciences Inc. Launches First Major United States Marketing Campaign
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 18, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has announced the first multimedia campaign for VINIA™ in the USA, Phase 1. The company is scaling up its US marketing in line with a 2022 growth plan that aims for significant growth in sales orders following commercial entry in 2021. "We are delighted to launch our first integrated marketing campaign aimed at expanding our...
2022-08-18 7:30 AM EDT
BioHarvest Sciences Inc. Commences Trading on the OTCQB Market
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 18, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") ") is pleased to announce that its common shares are now trading on the OTCQB® Venture Market under the ticker symbol "CNVCF". "Admission to the OTCQB® market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of transparency as we expand both our...
2022-07-18 7:30 AM EDT
BioHarvest Sciences Inc. Receives the Largest Ever VINIA Purchase Order from BATORY Foods
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") today announced that Batory Foods (Batory) has placed a purchase order for 1,000 kg of VINIA®, to be delivered by end of December 2022. Batory Foods
2022-07-07 7:30 AM EDT
BioHarvest Sciences Inc. Reports Strong Q2 2022 Results with Major Achievements on All Fronts
British Columbia and Rehovot, Israel--(Newsfile Corp.
2022-07-05 7:30 AM EDT
BioHarvest Sciences Inc. Announces Appointment of Gavriel Lambert to the Board of Advisors
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") today announced that effective immediately, Gavriel Lambert will be serving on its Board of Advisors. Gavriel brings 27 years of experience in global investment banking and will complement BioHarvest's highly competent Bo
2022-06-30 2:20 PM EDT
BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include coverage of Q2 sales results and a detailed progress update on the 2022 Growth Priorities,...
2022-06-24 9:00 AM EDT
BioHarvest Sciences Hires Dr. Brian S. Cornblatt as Chief Medical Officer
Rehovot, Israel--(Newsfile Corp. - May 31, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has hired Dr. Brian S. Cornblatt as its Chief Medical Officer, marking a significant milestone in the Company's route for the development of next generation therapeutic solutions including botanical drugs. Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In this role Dr....
2022-05-31 7:30 AM EDT
BioHarvest Sciences Unveils Profile of Unique Cannabis Composition
Rehovot, Israel--(Newsfile Corp. - May 12, 2022) - BioHarvest Sciences Inc. the (CSE: BHSC) ("BioHarvest" or the "company") today unveiled the composition profile of its full-spectrum Cannabis produced in large-scale industrial bioreactors based on its proprietary Bio-Plant CELLicitation™ platform technology. On December 8th, 2021, BHSC b
2022-05-12 7:00 AM EDT
BioHarvest Sciences Inc. Announces a Private Placement of up to USD $5 Million of Convertible Notes to Finance Production Facilities and Scaling of Core Business
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") announced today a financing plan based on a private placement of up to USD $5 Million (approximately $6.3 Million CAD). The funds raised will allow the Company to accelerate the growth plan for its polyphenols/antioxidants and Cannabis verticals. On March 23, 2021, BHSC announced the completion of the Company's Cannabis R&D...
2022-04-07 7:30 AM EDT
Bioharvest Sciences Inc. Reports Strong Q1 2022 Results on All of the Company's Activities
British Columbia and Rehovot, Israel--(Newsfile Corp. - April 6, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") today announced Q1 202
2022-04-06 7:30 AM EDT
Bioharvest Sciences Inc. Successfully Completes Cannabis R&D Program
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 23, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") today announced that it has produced Cannabis Biomass in large scale industrial bioreactors, which represents the completion of the Company's Cannabis R&D program. On December 8th, 2021, BHSC became the first company ever to announce that it could produce Cannabis biomass without growing the plant itself. Building on that breakthro
2022-03-23 7:00 AM EDT
BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event April 7, 2022, at 2:00 PM E.T.
Rehovot, Israel--(Newsfile Corp. - March 11, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, April 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include an unveiling of the 2022 Growth Priorities, including a detailed performance update on the commercialization of...
2022-03-11 7:00 AM EST